Fourth Annual Symposium on Risk, Diagnosis and Treatment of Cardiovascular Disease in Women: ★ CME Information

Abstract

Cardiovascular disease (CVD) is the number one killer of women in the United States. Long thought of as primarily affecting men, CVD—including heart disease, hypertension, and stroke—affects a substantial number of women. The number of CVD deaths for females has exceeded those for males since 1984.More than one in three female adults has some form of cardiovascular disease. Experts estimate that one in two women will die of heart disease or stroke, compared with one in 25 women who will die of breast cancer.Although heart disease is a complex disorder thought to be a result of interactions between genetic and environmental factors, it is 80% preventable with proven strategies for risk modification. Both patient and professional education about managing the risk factors shared by all cardiovascular diseases are essential and must be promoted across all disciplines encountering women in the health care field. The goal of this section to educate primary care physicians and cardiologists about diagnosis, treatment, and prevention of CVD in women.At the conclusion of this activity, the participant should be able to:Cardiologists, gynecologists, primary care physicians, internal medicine physicians, family medicine practitioners, endocrinologists, and nurse practitioners.Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.Texas Heart Institute designates this journal-based CME activity for a maximum of 5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The articles marked with a ★ are designated for CME credit.June 5, 2014, through June 5, 2016. Continuation of CME credit from June 5, 2016, depends upon a thorough review of the content for currency and accuracy.The following individuals have reported no interest or other relationship(s) with companies that may relate to the educational content of this activity:The Planning Committee members have nothing to disclose.The THI CME Staff have nothing to disclose.The Program Reviewers have nothing to disclose.The following individuals have reported that they have or have had financial relationships with commercial interests:Guilherme V. Silva, MD, is on the speakers' bureau for St. Jude Medical, Inc.If you previously completed and received credit for the live CME-sponsored symposium titled Fourth Annual Symposium on Risk, Diagnosis and Treatment of Cardiovascular Disease in Women, on October 19, 2013, please note that you will not receive credit for completing this activity. Participants who take part in an identical activity, even in order to validate learning or to clarify specific topics, cannot claim, nor will the Texas Heart Institute award, duplicate credit for the activity.To obtain CME credit for the Fourth Annual Symposium on Risk, Diagnosis and Treatment of Cardiovascular Disease in Women Texas Heart Institute Journal section, you must:For assistance or feedback on this activity, please contact the Texas Heart Institute Office of CME at 713-218-2200 or by e-mail at cme@texasheart.org.